Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.

BJOG : an international journal of obstetrics and gynaecology - 1 Oct 2018

Saramago P, Yang H, Llewellyn A, Palmer S, Simmonds M, Griffin S

Abstract excerpt

OBJECTIVE: To evaluate the cost-effectiveness of high-throughput, non-invasive prenatal testing (HT-NIPT) for fetal Rhesus D (RhD) genotype to guide antenatal prophylaxis with anti-D immunoglobulin compared with routine antenatal anti-D immunoglobulin prophylaxis (RAADP). DESIGN: Cost-effectiveness decision-analytic modelling. SETTING: Primary care. PARTICIPANTS: A simulated population of 100 000 RhD-negative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Fetus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Pregnancy Complications, Hematologic

Share to Prenatal Care

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 29415334
DOI: 10.1111/1471-0528.15152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.PMID 29415334Read ↗

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.Semantic proximity Read ↗

Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted ProphylaxisSemantic proximity Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Systematic Review of Economic Evaluations.Semantic proximity Read ↗

Implementation of high-throughput non-invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross-sectional survey of maternity units and expert interviews.Semantic proximity Read ↗

Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.Semantic proximity Read ↗

Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies.Semantic proximity Read ↗

Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

Fetal RHD genotyping is a cost-effective option for supporting targeted anti-D prophylaxis in D-negative pregnancies.Semantic proximity Read ↗

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.Semantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.